First Liver-Directed Therapy for Metastatic Uveal Melanoma Is Approved
- Posted on: Apr 12 2024
- Leave a response
The phase 3 FOCUS trial demonstrated favorable responses among patients with uveal melanoma treated with liver-directed melphalan, leading to FDA approval of the therapy in 2023.
Source: AAO
Posted in: Uncategorized
